174 related articles for article (PubMed ID: 22278332)
1. Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.
Marino SE; Birnbaum AK; Leppik IE; Conway JM; Musib LC; Brundage RC; Ramsay RE; Pennell PB; White JR; Gross CR; Rarick JO; Mishra U; Cloyd JC
Clin Pharmacol Ther; 2012 Mar; 91(3):483-8. PubMed ID: 22278332
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.
Ahmed GF; Brundage RC; Marino SE; Cloyd JC; Leppik IE; Pennell PB; Ramsay RE; Birnbaum AK
J Clin Pharmacol; 2013 Mar; 53(3):276-84. PubMed ID: 23408495
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy.
Tolbert D; Cloyd J; Biton V; Bekersky I; Walzer M; Wesche D; Drummond R; Lee D
Epilepsia; 2015 Jun; 56(6):915-23. PubMed ID: 25982590
[TBL] [Abstract][Full Text] [Related]
4. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and pharmacokinetics of carbamazepine oral loading doses.
Cohen H; Howland MA; Luciano DJ; Rubin RN; Kutt H; Hoffman RS; Leung LK; Devinsky O; Goldfrank LR
Am J Health Syst Pharm; 1998 Jun; 55(11):1134-40. PubMed ID: 9626375
[TBL] [Abstract][Full Text] [Related]
6. Effect of vigabatrin on the pharmacokinetics of carbamazepine.
Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I; Llopis P
J Clin Pharm Ther; 2002 Dec; 27(6):427-30. PubMed ID: 12472982
[TBL] [Abstract][Full Text] [Related]
7. Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.
Ahn JE; Cloyd JC; Brundage RC; Marino SE; Conway JM; Ramsay RE; White JR; Musib LC; Rarick JO; Birnbaum AK; Leppik IE
Neurology; 2008 Jul; 71(1):38-43. PubMed ID: 18591503
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of carbamazepine derived from a new tablet formulation.
Popović J; Mikov M; Jakovljevic V
Eur J Drug Metab Pharmacokinet; 1995; 20(4):297-300. PubMed ID: 8983936
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
Chan E; Lee HS; Hue SS
Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic drug monitoring and the pharmacokinetics of carbamazepine in children with a convulsive syndrome].
Kholodov LE; Prityko AG; Ivanova ES; Sokolov AV; Tishchenkova IF; Dubrovina LIu; Postnikov SS; Tatarinov PA; Kopanev IuA; Veselov NK
Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(3):35-40. PubMed ID: 7571921
[TBL] [Abstract][Full Text] [Related]
11. Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions.
Brewster ME; Anderson WR; Meinsma D; Moreno D; Webb AI; Pablo L; Estes KS; Derendorf H; Bodor N; Sawchuk R; Cheung B; Pop E
J Pharm Sci; 1997 Mar; 86(3):335-9. PubMed ID: 9050802
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly.
Cloyd JC; Marino S; Birnbaum AK
Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective pharmacokinetic analysis of the antiepileptic 10-hydroxycarbazepine in dogs.
Volosov A; Sintov A; Bialer M
Ther Drug Monit; 1999 Apr; 21(2):219-23. PubMed ID: 10217343
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
Deleu D; Aarons L; Ahmed IA
Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340
[TBL] [Abstract][Full Text] [Related]
16. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
Bedada SK; Appani R; Boga PK
Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
[TBL] [Abstract][Full Text] [Related]
17. Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers.
Vaz J; Kulkarni C; David J; Joseph T
Indian J Exp Biol; 1998 Jan; 36(1):112-4. PubMed ID: 9536660
[TBL] [Abstract][Full Text] [Related]
18. Effect of concomitantly administered honey on the pharmacokinetics of carbamazepine in healthy volunteers.
Malhotra S; Garg SK; Dixit RK
Methods Find Exp Clin Pharmacol; 2003 Sep; 25(7):537-40. PubMed ID: 14571284
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.
Stockis A; Sargentini-Maier ML; Brodie MJ
Epilepsy Res; 2016 Dec; 128():163-168. PubMed ID: 27842261
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates.
Aldenkamp AP; Rentmeester T; Hulsman J; Majoie M; Doelman J; Diepman L; Schellekens A; Franken M; Olling M
Eur J Clin Pharmacol; 1998 Apr; 54(2):185-92. PubMed ID: 9626926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
